• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, ILIAC Back to Search Results
Device Problems Fracture (1260); Migration or Expulsion of Device (1395)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Type  malfunction  
Manufacturer Narrative
On completion of the investigation a follow up report will be submitted.
 
Event Description
Article received: meijs, t.E.(2020).Epinephrine stress testing during cardiac catheterization in patients with aortic coarctation.American heart journal, 78-87.Purpose: we aimed to investigate whether epinephrine stress testing improves clinical decision making and outcome in coa.Method: we retrospectively evaluated coa patients (b)(6) kg with a peak systolic gradient (psg) =20 mm hg during cardiac catheterization who underwent epinephrine stress testing.Subsequent interventional management (stenting or balloon dilatation), complications, and medium-term clinical outcome were assessed.Conclusion: in coa patients with a low baseline psg but high epinephrine psg, percutaneous intervention is associated with a substantial reduction in systemic blood pressure and the use of antihypertensive medication.Per the article product problems included stent fracture and stent migration.
 
Manufacturer Narrative
Article reviewed: meijs, et al.(2020).Epinephrine stress testing during cardiac catheterization in patients with aortic coarctation.Am heart journal; 225:78-87.The subject article is retrospective observational study of 50 patients with aortic coarctation (coa) who were >50 kg with a peak systolic gradient (psg) =20 mm hg during cardiac catheterization who underwent epinephrine stress testing.Subsequent interventional management (stenting or balloon dilatation), complications, and medium-term clinical outcome were assessed.This complaint is based on information found within a article/literature review.There was no product that was available for evaluation, therefore a device evaluation could not be conducted and the complaint cannot be confirmed.The author of the article did not report any major adverse patient effects as result of this event.A device history record (dhr) review was unable to be performed as the device product part number and lot number was not provided within the article.Attempts to obtain the device lot information was conducted but unsuccessful.The hazardous situation/harm is addressed in the risk file and is operating within its risk profile.There was no evidence within the article that the device was the cause of the reported event.The complaint history review did not identify an adverse trend, therefore no escalation to capa process is required.Conclusion: considering the retrospective observational design of the study with a relatively small sample size, high technical success rate, and the fact that percutaneous intervention is associated with a substantial reduction in systemic blood pressure and the use of antihypertensive medication, one can infer that getinge¿s advanta v12tm balloon expandable covered stents performed as expected.The authors do not attribute development of complications to any particular stent type.H3 other text: not available for return.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTA V12 COVERED STENT
Type of Device
STENT, ILIAC
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer Contact
lori gosselin
40 continental blvd
merrimack, NH 
MDR Report Key11355966
MDR Text Key234212740
Report Number3011175548-2021-00194
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-